De‐escalating radical surgery for select FIGO Stage I cervical cancer
International Journal of Gynecology & Obstetrics · 2026-09 · 174 (3) · 1181-1187
DOI: 10.1002/ijgo.71230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 27.07.2026. Verfasst von Sara Moufarrij und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Hysterectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Four recent prospective trials demonstrated that de‐escalation of radical surgery for select patients with apparent low‐risk, FIGO Stage I cervical cancer does not compromise cancer‐related survival but does improve quality of life and provide the opportunity to preserve fertility. We present a critical review of ConCerv, SHAPE, GOG‐278, and LESSER, which have set the stage for de‐escalation of surgery for low‐risk, early‐stage cervical cancer. ConCerv, a prospective phase II study evaluating the feasibility and oncologic outcomes of conization alone or simple hysterectomy in patients with early‐stage cervical carcinoma, found a low recurrence rate of 2.4% in patients who underwent a cone biopsy with lymph node assessment and 0% in those who underwent simple hysterectomy with lymph node evaluation. SHAPE, a phase III trial assessing the safety of simple hysterectomy compared to radical hysterectomy in this patient population, showed no difference in pelvic recurrences between both groups. GOG‐278, an international cohort study evaluating the efficacy of cone biopsy versus simple hysterectomy with pelvic nodal assessment, found a 3‐year recurrence‐free survival rate of 94.8% in the cone biopsy group, with no recurrences noted in the simple hysterectomy group. Finally, LESSER, a phase II proof‐of‐concept trial studying cancer and quality‐of‐life outcomes in patients who underwent either a simple or modified radical hysterectomy for early‐stage cervical cancer, found no difference in the disease‐free survival rate or overall survival between both groups. Rates of postoperative complications were also similar in both arms. Based on these trials, we propose the following set of criteria for which de‐escalation of surgical intervention would be appropriate for select Stage I disease: tumors ≤2 cm on cone biopsy; magnetic resonance imaging showing
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Clínica de Oncología Astorga, Medellín, Colombia.
- Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
- Division of Gynecologic Oncology, Clínica Internacional de Alta Tecnología-CLINALTEC, Inbagué, Colombia.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Moufarrij, S., Pareja, R., Fletcher, A., Wilailak, S., Abu-Rustum, N. R., & FIGO Committee on Women's Cancer (2026). De‐escalating radical surgery for select FIGO Stage I cervical cancer. International Journal of Gynecology & Obstetrics, 174(3), 1181-1187. https://doi.org/10.1002/ijgo.71230
Vancouver
Moufarrij S, Pareja R, Fletcher A, Wilailak S, Abu-Rustum NR, FIGO Committee on Women's Cancer. De‐escalating radical surgery for select FIGO Stage I cervical cancer. International Journal of Gynecology & Obstetrics. 2026;174(3):1181-1187. doi:10.1002/ijgo.71230
BibTeX
@article{Moufarrij2026,
author = {Moufarrij, Sara and Pareja, Rene and Fletcher, Angélica and Wilailak, Sarikapan and Abu-Rustum, Nadeem R and FIGO Committee on Women's Cancer, FIGO Committee on Women's Cancer},
title = {De‐escalating radical surgery for select FIGO Stage I cervical cancer},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {174},
number = {3},
pages = {1181--1187},
doi = {10.1002/ijgo.71230}
}
EUVIMED